黄体期无排卵卵泡产生能发育为囊胚的卵母细胞:同一卵巢周期内卵泡期与黄体期刺激的自身配对病例对照研究
本研究在同一卵巢周期内对188例预后不良患者行卵泡期刺激(FPS)和黄体期刺激(LPS),比较两组卵母细胞及囊胚结局。LPS组获卵数、囊胚数及获得囊胚的几率均高于FPS组,而两组囊胚率、整倍体率及整倍体囊胚移植后的持续妊娠/分娩率无显著差异。
要点
- LPS组平均囊胚数高于FPS组(1.6±1.6 vs 1.2±1.1,P<0.01)。
- LPS组获卵数多于FPS组(4.3±2.8 vs 3.6±2.1,P<0.01)。
- 两组整倍体囊胚移植后持续妊娠/分娩率无显著差异。
核心结论
- LPS来源的卵母细胞与FPS来源的卵母细胞具有相似的发育潜能,且LPS可获得更多囊胚。
- 上述数据为LPS用于预后不良及肿瘤患者提供了证据,并对卵泡募集的「单次募集」理论提出质疑。
研究设计与样本
- 自身配对病例对照研究,于2015年10月至2017年12月在两家私立IVF诊所开展。
- 纳入188例预后不良患者,在同一卵巢周期内行DuoStim,即先后进行卵泡期刺激(FPS)和黄体期刺激(LPS),并采用胚胎植入前非整倍体遗传学检测(PGT-A)。
主要发现
- FPS组平均囊胚数少于LPS组:1.2±1.1 vs 1.6±1.6,P<0.01。
- FPS组获卵数少于LPS组:3.6±2.1 vs 4.3±2.8,P<0.01。
- FPS组与LPS组平均每次取卵的囊胚率无显著差异:33.1%±30.3% vs 37.4%±30.8%,P=NS。
- FPS组获得囊胚的几率低于LPS组:67.6%(n=127/188,95%CI:60.3-74.1)vs 77.1%(n=145/188,95%CI:70.3-82.8),P=0.05。
- FPS组与LPS组平均每次取卵的整倍体率无显著差异:13.6%±22.8% vs 16.3%±23.4%,P=NS;FPS组平均整倍体囊胚数少于LPS组:0.5±0.8 vs 0.7±1.0,P=0.02。
关键数值与推荐
- FPS和LPS均采用拮抗剂方案,每日给予相同剂量的重组促性腺激素。
- FPS组与LPS组整倍体单囊胚移植后的持续妊娠/分娩率无显著差异:42.4%(n=28/66,95%CI:30.5-55.2)vs 53.8%(n=35/65,95%CI:41.1-66.1),P=NS。
临床怎么用
- 作者认为,这些数据为LPS用于预后不良和肿瘤患者提供了支持,并对卵泡募集的「单次募集」理论提出质疑。
- 作者建议未来需开展更多研究以证实LPS的安全性,尤其关注卵巢和卵泡环境以及临床、围产期和产后结局。
局限性
- 未来需开展更多研究以证实LPS的安全性,尤其关注卵巢和卵泡环境以及临床、围产期和产后结局。
- 本研究为初步数据,提示FPS与LPS来源的整倍体囊胚持续着床/分娩率(>22周)相似,未来需在预后不良患者以外的人群中扩展验证,并采用DuoStim以外的方法,同时持续监测相关围产期和产后结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Are the mean numbers of blastocysts obtained from sibling cohorts of oocytes recruited after follicular phase and luteal phase stimulations (FPS and LPS) in the same ovarian cycle similar? SUMMARY ANSWER: The cohorts of oocytes obtained after LPS are larger than their paired-FPS-derived cohorts and show a comparable competence, thus resulting in a larger mean number of blastocysts. WHAT IS KNOWN ALREADY: Three theories of follicle recruitment have been postulated to date: (i) the 'continuous recruitment' theory, (ii) the 'single recruitment episode' theory and (iii) the 'wave' theory. Yet, a clear characterization of this crucial biological process for human reproduction is missing. Recent advances implemented in in vitro fertilization (IVF), such as blastocyst culture, aneuploidy testing and vitrification, have encouraged clinicians to maximize the exploitation of the ovarian reserve through tailored stimulation protocols, which is crucial especially for poor prognosis patients aiming to conceive after IVF. LPS has been already successfully adopted to treat poor prognosis or oncological patients through Duostim, LPS-only or random-start ovarian stimulation approaches. Nevertheless, little, and mainly retrospective, evidence has been produced to support the safety of LPS in general. Feasibility of the LPS approach would severely question the classic 'single recruitment episode' theory of follicular development. STUDY DESIGN, SIZE, DURATION: This case-control study was conducted with paired follicular phase- and luteal phase-derived cohorts of oocytes collected after stimulations in the same ovarian cycle (DuoStim) at two private IVF clinics between October 2015 and December 2017. PARTICIPANTS/MATERIALS, SETTING, METHODS: The study included 188 poor prognosis patients undergoing DuoStim with preimplantation genetic testing for aneuploidies (PGT-A). FPS and LPS were performed with the same daily dose of recombinant-gonadotrophins in an antagonist protocol. Blastocyst culture, trophectoderm biopsy, vitrification and frozen-warmed euploid single blastocyst transfers were performed. The primary outcome was the mean number of blastocysts obtained per oocyte retrieval from paired-FPS- and LPS-derived cohorts (required sample size = 165 patients; power = 90%). Mean blastulation and euploidy rates were monitored, along with the number of oocytes, euploid blastocysts and clinical outcomes. MAIN RESULTS AND THE ROLE OF CHANCE: Significantly fewer blastocysts were obtained after FPS than LPS (1.2 ± 1.1 vs. 1.6 ± 1.6, P < 0.01), due to fewer oocytes collected (3.6 ± 2.1 vs. 4.3 ± 2.8, P < 0.01) and a similar mean blastocyst rates per retrieval (33.1% ± 30.3% vs. 37.4% ± 30.8%, P = NS). The number of oocytes collected were correlated (R = 0.5, P < 0.01), while the blastocyst rates were uncorrelated among paired-FPS- and LPS-derived cohorts. Overall, a significantly lower chance of producing blastocyst(s) was reported after FPS than after LPS: 67.6% (n = 127/188, 95%CI: 60.3-74.1) vs. 77.1% (n = 145/188, 95%CI: 70.3-82.8; P = 0.05). The mean euploidy rates per retrieval were similar between FPS- and LPS-derived cohorts of oocytes (13.6% ± 22.8% vs. 16.3% ± 23.4%, P = NS). Therefore, on average fewer euploid blastocysts (0.5 ± 0.8 vs. 0.7 ± 1.0, P = 0.02) resulted from FPS. Similar ongoing-pregnancy/delivery rates were reported, to date, after FPS- and LPS-derived euploid single blastocyst transfers: 42.4% (n = 28/66, 95%CI: 30.5-55.2) vs. 53.8% (n = 35/65, 95%CI: 41.1-66.1; P = NS). LIMITATIONS, REASONS FOR CAUTION: More studies need to be conducted in the future to confirm the safety of LPS, especially in terms of ovarian and follicular environment, as well as the clinical, peri-natal and post-natal outcomes. Here, we showed preliminary data suggesting a similar ongoing implantation/delivery rate (>22 weeks) between FPS- and LPS-derived euploid blastocysts, that need to be extended in the future, to populations other than poor prognosis patients and using approaches other than DuoStim together with a constant monitoring of the related peri-natal and post-natal outcomes. WIDER IMPLICATIONS OF THE FINDINGS: These data, from a paired study design, highlight that LPS-derived oocytes are as competent as FPS-derived oocytes, thereby adding some evidence to support the use of LPS for poor prognosis and oncological patients and to question the 'single recruitment episode' theory of follicle recruitment. These findings also encourage additional studies of the basics of folliculogenesis, with direct clinical implications for the management of ovarian stimulation in IVF. TRIAL REGISTRATION: None. STUDY FUNDING/COMPETING INTEREST(S): No external funds were used for this study and there are no conflicts of interest.
引用
- Cimadomo D, Vaiarelli A, Colamaria S, et al. Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle. Hum Reprod. 2018. PMID: 29912374. doi:10.1093/humrep/dey217
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。